Form 8-K Dolby Laboratories, Inc. For: Jan 12
�
�
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
�
�
FORM 8-K
�
�
CURRENT REPORT
Pursuant to Section�13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
January�12, 2015
�
�
DOLBY LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
�
�
�
Delaware | � | 001-32431 | � | 90-0199783 |
(State or other jurisdiction of incorporation) |
� | (Commission File Number) |
� | (IRS Employer Identification No.) |
100 Potrero Avenue
San Francisco, CA 94103-4813
(Address of principal executive offices) (Zip Code)
(415) 558-0200
(Registrant�s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
�
�
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
�
� | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
�
� | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
�
� | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
�
� | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
�
�
�
Item�5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On January�12, 2015, Michael Rockwell notified Dolby Laboratories, Inc. (the �Company�) of his resignation as the Company�s Executive Vice President, Advanced Technology Group, effective January�30, 2015.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
�
� | DOLBY LABORATORIES, INC. | |
By: | � | /s/ Andy Sherman |
� | Andy Sherman Executive Vice President, General Counsel and Secretary |
Date: January�15, 2015
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
- INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against FiscalNote Holdings, Inc. and Encourages Investors to Contact the Firm
- ROSEN, NATIONAL TRIAL LAWYERS, Encourages Northern Genesis Acquisition Corp. n/k/a The Lion Electric Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – NGA
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!